Terapia con LAMA/LABA nelle GOLD 2017 per la BPCO • NCF
Population-based study of LAMA monotherapy effectiveness compared with LABA/ LAMA as initial treatment for COPD in primary care | npj Primary Care Respiratory Medicine
Navigating New Treatment Options for COPD | Consultant360
American College of Chest Physicians - In a real-world setting, LAMA-LABA-ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
COPD Medications: Types and Benefits - COPD info
Chronic obstructive pulmonary disease (COPD) - Management Approach | BMJ Best Practice
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy
PDF] Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA | Semantic Scholar
What Is the Role of Dual LAMA/LABA Bronchodilation in COPD Therapy in Light of New Clinical Data? - ppt download
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
Approved fixed-dose combinations of LABAs and LAMAs for COPD treatment | Download Scientific Diagram
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text
LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect
In Depth | Anoro Ellipta: first LABA/LAMA combination inhaler for COPD
LAMA/LABA Fixed-dose Combo May Be Superior for COPD Therapy | RT
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
Frontiers | Single Inhaler LABA/LAMA for COPD
A new alphabet for COPD care | European Respiratory Society
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? | Respiratory Research | Full Text
COPD Inhalers - Easy to Use Reference Tool - CommPharm Consulting